Effect of topical motesanib in experimental corneal neovascularization model-Reference-Cited by-同舟云学术

Effect of topical motesanib in experimental corneal neovascularization model

Published:2023-03-27 Issue:8 Volume:43 Page:2989-2997
ISSN:1573-2630
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Çelenk Mukaddes^ORCID,Yıldırım Hakan^ORCID,Tektemur Ahmet^ORCID,Balbaba Mehmet^ORCID,Erdağ Murat^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s10792-023-02685-3.pdf

Reference40 articles.

1. Zhang SX, Ma JX (2007) Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 26:1–37

2. Feizi S, Azari AA, Safapour S (2017) Therapeutic approaches for corneal neovascularization. Eye and Vision 4:1–10

3. Philipp W, Speicher L, Humpel C (2000) Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Investig Ophthalmol Visual Sci 41:2514–2522

4. Ho QT, Kuo CJ (2007) Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol 39:1349–1357

5. Gan L, Fagerholm P, Palmblad J (2004) Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand 82:557–563

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Tear Vascular Endothelial Growth Factor and External Eye Diseases;International Journal of Molecular Sciences;2024-01-23

2. Effect of a protein kinase B (Akt) inhibitor on the angiogenesis of HUVECs and corneal neovascularization;Wiener klinische Wochenschrift;2023-06-01